Press Releases Trinity Biotech plc

Equities

TRIB

US8964385046

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Other stock markets 10:37:21 2026-05-21 am EDT			5-day change	1st Jan Change
0.6102 ^USD	+0.96%		+4.54%	-22.86%

May. 20	European Equities Traded in US as ADRs Rise in Wednesday Trading	MT
May. 18	European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading	MT

Press Releases

May. 01	Trinity Biotech : Financial Results for Quarter 4, 2025 and FY2025	PU
May. 01	Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations	AQ
Mar. 24	Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test	AQ
Mar. 18	Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren’s Syndrome	AQ
Mar. 12	Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System	AQ
Mar. 11	Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program	AQ
Mar. 10	Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform	AQ
Mar. 10	Trinity Biotech Provides Business and Trading Update	AQ
Feb. 25	Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives	AQ
Feb. 20	Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares	AQ
Feb. 13	Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement	AQ
Feb. 10	Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation	AQ
Feb. 10	Trinity Biotech Glucose Monitoring Innovation Achieves Unique Global Recognition: Diabetes Care Premier Hb9210™ HbA1c Analyser Becomes the Only System Awarded Prestigious IFCC Gold Classification for 2026	AQ
Dec. 23	Trinity Biotech : Financial Results for Quarter 3, 2025	PU
Dec. 23	Trinity Biotech : Financial Results for Quarter 2, 2025	PU
Dec. 23	Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives	AQ
Dec. 23	Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests	AQ
Dec. 15	Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances	AQ
Nov. 18	Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation	AQ
Nov. 17	Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test	AQ
Nov. 14	Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test	AQ
25-10-27	Trinity Biotech Welcomes Perceptive Advisor’s Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting Growth	AQ
25-09-08	Trinity Biotech : Annual Report 2024	PU
25-09-08	Trinity Biotech : 2025 AGM Company Secretary's Letter Sent to holders of Ordinary Shares	PU
25-09-08	Trinity Biotech : 2025 AGM Notice Sent to holders of Ordinary Shares	PU